Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Ut Southwestern Medical Center
Dallas, Texas
The records below are financial disclosure and conflict of interest records obtained by ProPublica from the National Institutes of Health and dozens of large public universities across the country. The NIH only has records for researchers who seek or receive its funding.
Total Disclosures: 94
| Name | Type | Company | Disclosed Value | Year Filed |
|---|---|---|---|---|
| Philip Thomas | Conflict of Interest | ReCode Therapeutics | >$600,000 | 2017 |
| Marc Diamond | Conflict of Interest | Washington University in St. Louis | >$600,000 | 2016 |
| Marc Diamond | Conflict of Interest | Washington University in St. Louis | >$600,000 | 2016 |
| Philip Thomas | Conflict of Interest | Reata Pharmaceuticals | $550,000 - $599,999 | 2014 |
| Deepak Nijhawan | Conflict of Interest | Peloton Therapeutics | $100,000 - $149,999 | 2018 |
| Zbyszek Otwinowski | Conflict of Interest | HKL Research, Inc | $100,000 - $149,999 | 2016 |
| Zbyszek Otwinowski | Conflict of Interest | HKL Research Inc | $100,000 - $149,999 | 2018 |
| Zbyszek Otwinowski | Conflict of Interest | HKL Research, Inc | $80,000 - $99,999 | 2016 |
| Jinming Gao | Conflict of Interest | OncoNano Medicine LLC | $60,000 - $79,999 | 2016 |
| Beth Levine | Conflict of Interest | Casma Therapeutics | $60,000 - $79,999 | 2019 |
| Zbyszek Otwinowski | Conflict of Interest | HKL Research Inc | $60,000 - $79,999 | 2018 |
| Baran Sumer | Conflict of Interest | OncoNano Medicine LLC | $60,000 - $79,999 | 2016 |
| Eric Olson | Conflict of Interest | Exonics Therapeutics | $60,000 - $79,999 | 2017 |
| Ian Neeland | Conflict of Interest | Boehringer Ingelheim(BI)/Lilly Alliance (BI/Lilly) | $60,000 - $79,999 | 2018 |
| Deepak Nijhawan | Conflict of Interest | Peloton Therapeutics | $20,000 - $39,999 | 2018 |
| David Holtzman | Conflict of Interest | C2N Diagnostics | $20,000 - $39,999 | 2016 |
| Philip Thomas | Conflict of Interest | ReCode Therapeutics | $20,000 - $39,999 | 2017 |
| Rhonda Bassel-Duby | Conflict of Interest | Exonics Therapeutics | $20,000 - $39,999 | 2018 |
| Jef Debrabander | Conflict of Interest | Revolution Medicines | $20,000 - $39,999 | 2016 |
| Joseph Ready | Conflict of Interest | Rodeo Therapeutics | $20,000 - $39,999 | 2017 |
| Ian Neeland | Conflict of Interest | Boehringer Ingelheim(BI)/Lilly Alliance (BI/Lilly) | $20,000 - $39,999 | 2018 |
| Beth Levine | Conflict of Interest | Casma Therapeutics | $5,000 - $9,999 | 2019 |
| Philip Thomas | Conflict of Interest | ReCode Therapeutics | $0 - $4,999 | 2017 |
| Rhonda Bassel-Duby | Conflict of Interest | Exonics Therapeutics | $0 - $4,999 | 2018 |
| Jef Debrabander | Conflict of Interest | Revolution Medicines | $0 - $4,999 | 2016 |
| Rhonda Bassel-Duby | Conflict of Interest | Exonics Therapeutics | $0 - $4,999 | 2018 |
| Philip Thomas | Conflict of Interest | ReCode Therapeutics | $0 - $4,999 | 2017 |
| Eric Olson | Conflict of Interest | Exonics Therapeutics | $0 - $4,999 | 2017 |
| Jef Debrabander | Conflict of Interest | Revolution Medicines | $0 - $4,999 | 2016 |
| Joseph Ready | Conflict of Interest | Rodeo Therapeutics | $0 - $4,999 | 2017 |
| Deepak Nijhawan | Conflict of Interest | Peloton Therapeutics | $0 - $4,999 | 2018 |
| Eric Olson | Conflict of Interest | Exonics Therapeutics | $0 - $4,999 | 2017 |
| Rhonda Bassel-Duby | Conflict of Interest | Exonics Therapeutics | $0 - $4,999 | 2018 |
| Eric Olson | Conflict of Interest | Exonics Therapeutics | $0 - $4,999 | 2017 |
| Zbyszek Otwinowski | Conflict of Interest | HKL Research Inc | $0 - $4,999 | 2018 |
| William Kraus | Conflict of Interest | Ribon Therapeutics | $0 - $4,999 | 2015 |
| William Kraus | Conflict of Interest | Ribon Therapeutics | $0 - $4,999 | 2015 |
| Zbyszek Otwinowski | Conflict of Interest | HKL Research, Inc | $0 - $4,999 | 2016 |
| Joseph Ready | Conflict of Interest | Rodeo Therapeutics | $0 - $4,999 | 2017 |
| Joseph Ready | Conflict of Interest | Rodeo Therapeutics | $0 - $4,999 | 2017 |
| Zbyszek Otwinowski | Conflict of Interest | HKL Research Inc | $0 - $4,999 | 2018 |
| Zbyszek Otwinowski | Conflict of Interest | HKL Research, Inc | $0 - $4,999 | 2016 |
| Sanford Markowitz | Conflict of Interest | Rodeo Therapeutics | $0 - $4,999 | 2017 |
| Sanford Markowitz | Conflict of Interest | Rodeo Therapeutics | $0 - $4,999 | 2017 |
| Stanton Gerson | Conflict of Interest | Rodeo Therapeutics | $0 - $4,999 | 2017 |
| Stanton Gerson | Conflict of Interest | Rodeo Therapeutics | $0 - $4,999 | 2017 |
| Jinming Gao | Conflict of Interest | OncoNano Medicine LLC | $0 - $4,999 | 2016 |
| Baran Sumer | Conflict of Interest | OncoNano Medicine LLC | $0 - $4,999 | 2016 |
| Jinming Gao | Conflict of Interest | OncoNano Medicine LLC | $0 - $4,999 | 2016 |
| William Kraus | Conflict of Interest | Ribon Therapeutics | $0 - $4,999 | 2015 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.